Latest News

Proactive news headlines: Sensyne Health, Braveheart Investment, Remote Monitored Systems, Aminex …


Sensyne Health PLC (LON:SENS) has agreed a research collaboration with Bristol Myers Squibb that will see it deploy its artificial intelligence and machine learning technology to help better understand certain rare blood diseases. Work will focus on Myeloproliferative Neoplasms to assess the progression of these blood cancers that are characterised by the over-production of white or red cells, or platelets. No financial terms were disclosed. This is Sensyne’s fourth partnership with a major pharma company following deals with Bayer, Roche and Alexion.

Braveheart Investment Group PLC (LON:BRH) has said a new antiviral face mask that can kill coronavirus (COVID-19) will go on sale by the end of the year. This follows a flurry of activity at Braveheart investee company Pharm2Farm (P2F), which has developed a textile coating incorporating nanoparticles with long-lasting virucidal properties. It now has testing results from two independent labs that show the mask textile has a ‘kill rate’ of over 90% for up to seven hours, meeting the requirements for ISO 18184 certification. Meanwhile, Braveheart’s sale of its 51.72% stake in P2F to Remote Monitored Systems PLC (LON:RMS) is expected to complete on November 5. As a result, Braveheart will own 37.12% of RMS.

Aminex PLC (LON:AEX) has announced the completion of its farm-out deal with ARA Petroleum Tanzania Limited (APT). “We are delighted to finally complete the farm-out and hand over operatorship of the Ruvuma PSA to APT,” said Robert Ambrose, Aminex chief executive in a statement. The company now retains a 25% interest in the Ruvuma asset – which includes the Ntorya gas project and exploration areas – and APT will fund a forward programme including the drilling of the Chikumbi-1 well and a new seismic programme over at least 200 square kilometres.

CMC Markets PLC (LON:CMCX) said it expects new Australian retail financial trading regulations to have a similar, although smaller, impact to those imposed in Europe two years ago. The Australian Securities and Investments Commission (ASIC) has confirmed changes, which are due to be implemented from March 29 next year, will restrict leverage on contracts for difference for retail traders at the same maximum ratios as those implemented by the European Securities and Markets Authority.

Avation PLC (LON:AVAP), the civil aircraft lessor, said it stayed in profit in its latest financial year in spite of the problems facing airlines due to coronavirus restrictions. Profits dropped 43% to US$14.3mln in the year to end June 2020, which was largely the result of US$35.5mln of impairment losses offset partially by an unrealised gain of US$27.1mln for purchase rights with plane manufacturer ATR. Revenue increased by 14% to US$135.3mln during the year, which was a new record said the company, and before the one-offs profits rose 28% to US$19.8mln.

Powerhouse Energy Group PLC (LON:PHE) has told investors that Dr Cameron Davies will retire as a director of the company on March 31, 2021. The company intends to appoint Mark Berry as a non-executive director. He is a partner in law firm Norton Rose Fulbright which has particular expertise in the energy industry, Powerhouse noted.

Shanta Gold Limited (LON:SHG) has announced that the books have closed on its placing and share subscription which was “significantly oversubscribed”. In Friday’s brief statement, the company added that it was working with its advisors on final allocations and would provide a further update in due course. Shanta announced after the market close on Thursday that it was proposing to raise roughly £31mln by way of a placing and a direct subscription of shares priced at 16.5p each.

US Oil & Gas PLC (USOP) has said it believes well drilling in the fourth quarter of 2020 remains a reasonable expectation, and it has finalised plans for the programme as it awaits regulatory approval. The company plans to drill the Eblana-9 well, at Railroad Valley in Nevada, as a straight hole with no deviation, down to a target depth of 5,300 feet. It also aims to test three potential producer zones of interest. Once drilled, it is the company’s intention to carry out a drill stem test to determine if the well is likely to produce at commercial rates.

Pan African Resources plc (LON:PAF) has said its American depositary receipts (ADRs) are to be traded on the OTCQX Best Market, starting Friday, October 23, 2020. The OTCQX market is the highest tier of the over-the-counter (OTC) market operated by OTC Markets Group. The ADRs were previously traded on the Pink OTC market.

Metal Tiger PLC (LON:MTR) has taken a 0.3% stake in Predictive Discovery Limited, a West Africa-focused gold explorer. The AIM-listed resources investor has subscribed for around 2.68mln shares in a placing currently being undertaken by ASX-listed Predictive to raise A$10.6mln at a price of 5.6 cents. Predictive has recently started the second phase of its drilling programme at its flagship Bankan Project in Guinea’s Siguiri Basin.

Bushveld Minerals Limited (LON:BMN), the AIM-quoted, integrated primary vanadium producer and energy storage provider, with ownership of high-grade assets in South Africa, has announced the receipt of Exchange Control authorisation from the South African Reserve Bank Financial Surveillance Department, a key condition for the completion of its US$30mln Production Financing transaction with Orion Mine Finance announced on September 30, 2020. The remaining material conditions outstanding before completion are: Execution and delivery of certain security documents to Orion; Provision of certain legal opinion(s) in relation to the Borrower and each of its guarantors; and Agreeing revised terms or prepayment with Nedbank in relation to the Nedbank Financing (including all amendments required to the Finance Documents in a form approved by Orion). In a statement, Fortune Mojapelo, CEO of Bushveld Minerals commented:  “Exchange Control authorisation from the South African Reserve Bank Competition Commission marks a key milestone in completing this transaction. Progress is being made in respect to the remaining conditions and we will update the market accordingly.”

InnovaDerma PLC (LON:IDP) said the search for a new chief executive is progressing very well. Kieran Callan stepped down in August and was replaced by Joe Bayer, who has been serving both as interim boss and executive chairman. The developer of beauty, personal care and life science products added that it received a requisition notice from Edale Capital, a shareholder holding in excess of 5% of the total voting capital.

Chaarat Gold Holdings Ltd (LON:CGH) has completed a refinancing and extended its US$19.4mln investor loan plus US$1.1mln of accrued interest. It has also issued 7.5mln of new shares and US$1mln of convertible loan notes to its largest shareholder Labro Investments in connection to the part of the debt that it refinanced. Labro’s shareholding increases to 211mln new shares, equivalent to 39.67% of the company’s share capital – and 40% if loan notes are fully exercised.

Power Metal Resources PLC (LON:POW) the AIM-listed metals exploration and development company said it has received notices to exercise warrants over 7,136,000 new ordinary shares of 0.1 pence each in the company. The warrant shares are being issued under the exercise for 4,636,000 warrants at an exercise price of 1.0p each and 2,500,000 warrants at an exercise price of 0.7p each. Subscription monies of £63,860 have been received by Power Metal in respect of these exercises.

Collagen Solutions PLC (LON:COS), the developer and manufacturer of biomaterials and regenerative medicines for the enhancement and extension of human life, announced that at its annual general meeting held on Friday, all resolutions were duly passed.

Itaconix PLC (LON:ITX) (OTCQB:ITXXF) announced that all resolutions set out in the notice of annual general meeting sent to shareholders were duly passed at the meeting held on Friday.

Tiziana Life Sciences PLC (NASDAQ:TLSA) (LON:TILS), a biotechnology company focused on innovative therapeutics for oncology, inflammation and infectious diseases, said it has allotted and issued 285,714 ordinary shares of 3p each credited as fully paid at a price of 35p per share in respect of the exercise of 285,714 warrants held by a warrant holder.

Stobart Group PLC (LON:STOB), the aviation and energy infrastructure group, has said it will announce its interim results for the six months ended August 31, 2020, on Wednesday, November 4, 2020. The group will hold an investor presentation at 9.30am UK time on the same day hosted by Warwick Brady, its chief executive officer and Lewis Girdwood, its chief financial officer. The presentation will be hosted through the digital platform Investor Meet Company. Investors can access the webcast by visiting:

Hardman & Co Research has issued a Q&A note with Dr Martin Hall of Advanced Oncotherapy PLC (LON:AVO). In the note Martin explains what’s been happening with the company lately, the potential advantages of LIGHT, how close it is to the first system, how the company is funding all the work and what investors and potential investors can look forward to over the coming months. To listen to the interview click on the following link:

Sewage testing identifies spikes in coronavirus infections says UK government

Previous article

Powerhouse Energy shareholders applaud new board appointment

Next article

You may also like


Leave a reply

Your email address will not be published.

More in Latest News